Strides India President (Brands) Subroto Banerjee had stated that the acquisition of Solus and Solus Care divisions is of strategic significance , says report.
Strides Shasun has received CCI's approval to acquire Sun Pharmaceutical's two business divisions in India for Rs 165 crore, according to reports.
Strides India President (Brands) Subroto Banerjee had stated that the acquisition of Solus and Solus Care divisions is of strategic significance , says report.
Earlier, Sun Pharma and Strides signed an agreement related to Ranbaxy's 'Solus' and 'Solus Care' divisions that are into central nervous system (CNS) segment in India.
Earlier, Sun Pharma and Strides signed an agreement related to Ranbaxy's 'Solus' and 'Solus Care' divisions that are into central nervous system (CNS) segment in India.
No comments:
Post a Comment